Kronos Bio, Inc. (KRON) Financials

KRON Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 238.0 million 59.4 million
2023-06-30 260.6 million 57.3 million
2023-03-31 289.0 million 63.4 million
2022-12-31 294.9 million 50.4 million

KRON Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -22.8 million 6.3 million
2023-06-30 -25.3 million 6.9 million
2023-03-31 -6.1 million 6.6 million
2022-12-31 -22.6 million 7.7 million

KRON Net Income

No data available :(

KRON Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 186.7 million - 29.5 million
2023-06-30 219.5 million - 30.2 million
2023-03-31 241.3 million - 31.0 million
2022-12-31 247.9 million - 31.1 million

KRON Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 58.1 million
2023-06-30 57.4 million
2023-03-31 57.1 million
2022-12-31 56.5 million

KRON Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 214000 25.3 million 9.4 million -
2023-06-30 308000 22.7 million 11.4 million -
2023-03-31 126000 19.7 million 10.1 million -
2022-12-31 52000 23.2 million 10.5 million -

KRON Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 917000 510000
2023-06-30 1.9 million 1.2 million
2023-03-31 1.2 million 1.2 million
2022-12-31 - 1.1 million

KRON

Price: $1.02

52 week price:
0.73
2.29

Earnings Per Share: -1.95 USD

P/E Ratio: -0.49

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 184700

Market Capitalization: 65.5 million

Links: